Pfizer is paying $1.25 billion to join the PD-(L1)xVEGF bispecific race. | Pfizer is paying $1.25 billion to join the ...

The FDA will limit the vaccine’s availability later this year to older adults and those who may be at risk of severe illness.

U.S. Food and Drug Administration advisers unanimously recommended on Thursday that COVID-19 vaccines for the 2025-26 period ...

At the outset of the meeting, the FDA's new top vaccine regulator, Vinay Prasad, said he and FDA leaders wanted to "give people a little more time to digest the policy." He said that the FDA is still ...

The notice came shortly after an advisory panel meeting at which members debated the pros and cons of asking manufacturers to ...

Point-of-care medication dispensing offers a return to a more straightforward approach, common to physician practices ...

The Trump administration released a 72-page report Thursday outlining its take on what's driving "a chronic disease crisis" ...

Latino News ...